Andlauer Healthcare Group Inc.
AND.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.19% | -3.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.19% | -3.74% | |||
| Cost of Revenue | -4.27% | -2.26% | |||
| Gross Profit | 2.03% | -6.62% | |||
| SG&A Expenses | 15.58% | 16.05% | |||
| Depreciation & Amortization | 4.06% | -0.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.15% | -0.42% | |||
| Operating Income | -9.20% | -21.33% | |||
| Income Before Tax | -24.98% | 2.99% | |||
| Income Tax Expenses | -1.57% | -22.48% | |||
| Earnings from Continuing Operations | -31.02% | 12.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.02% | 12.55% | |||
| EBIT | -9.20% | -21.33% | |||
| EBITDA | -6.86% | -24.69% | |||
| EPS Basic | -30.87% | 12.57% | |||
| Normalized Basic EPS | -6.97% | -17.32% | |||
| EPS Diluted | -30.87% | 12.61% | |||
| Normalized Diluted EPS | -7.12% | -17.51% | |||
| Average Basic Shares Outstanding | -0.22% | -0.02% | |||
| Average Diluted Shares Outstanding | -0.09% | 0.26% | |||
| Dividend Per Share | 3.71% | 6.36% | |||
| Payout Ratio | 0.50% | -0.06% | |||